Amalgamated Bank’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-61,373
| Closed | -$54K | – | 2965 |
|
|
2022
Q4 | $54K | Buy |
61,373
+11,289
| +23% | +$9.93K | ﹤0.01% | 2388 |
|
|
2022
Q3 | $79K | Buy |
50,084
+145
| +0.3% | +$229 | ﹤0.01% | 2261 |
|
|
2022
Q2 | $100K | Buy |
49,939
+2,519
| +5% | +$5.04K | ﹤0.01% | 2170 |
|
|
2022
Q1 | $110K | Sell |
47,420
-3,738
| -7% | -$8.67K | ﹤0.01% | 2159 |
|
|
2021
Q4 | $238K | Buy |
51,158
+3,001
| +6% | +$14K | ﹤0.01% | 1911 |
|
|
2021
Q3 | $367K | Sell |
48,157
-2,069
| -4% | -$15.8K | ﹤0.01% | 1748 |
|
|
2021
Q2 | $487K | Buy |
50,226
+14,592
| +41% | +$141K | ﹤0.01% | 1657 |
|
|
2021
Q1 | $295K | Sell |
35,634
-3,286
| -8% | -$27.2K | 0.01% | 1273 |
|
|
2020
Q4 | $266K | Buy |
38,920
+4,483
| +13% | +$30.6K | 0.01% | 1291 |
|
|
2020
Q3 | $384K | Buy |
34,437
+6,540
| +23% | +$72.9K | 0.02% | 987 |
|
|
2020
Q2 | $175K | Buy |
27,897
+6,415
| +30% | +$40.2K | 0.01% | 1322 |
|
|
2020
Q1 | $40K | Buy |
21,482
+976
| +5% | +$1.82K | ﹤0.01% | 1587 |
|
|
2019
Q4 | $69K | Hold |
20,506
| – | – | ﹤0.01% | 1771 |
|
|
2019
Q3 | $44K | Sell |
20,506
-178
| -0.9% | -$382 | ﹤0.01% | 1721 |
|
|
2019
Q2 | $55K | Buy |
20,684
+5,666
| +38% | +$15.1K | ﹤0.01% | 1740 |
|
|
2019
Q1 | $71K | Buy |
15,018
+596
| +4% | +$2.82K | ﹤0.01% | 1623 |
|
|
2018
Q4 | $35K | Buy |
+14,422
| New | +$35K | ﹤0.01% | 1591 |
|
|
2018
Q3 | – | Sell |
-13,381
| Closed | -$96K | – | 1656 |
|
|
2018
Q2 | $96K | Buy |
+13,381
| New | +$96K | ﹤0.01% | 1660 |
|